Invention Grant
- Patent Title: Oral cannabinoid formulations
-
Application No.: US16314569Application Date: 2017-06-29
-
Publication No.: US11291631B2Publication Date: 2022-04-05
- Inventor: Harshit Shah
- Applicant: GW Research Limited
- Applicant Address: GB Cambridge
- Assignee: GW Research Limited
- Current Assignee: GW Research Limited
- Current Assignee Address: GB Cambridge
- Agency: Cooley LLP
- Priority: EP1611547 20160701
- International Application: PCT/GB2017/051914 WO 20170629
- International Announcement: WO2018/002637 WO 20180104
- Main IPC: A23L27/30
- IPC: A23L27/30 ; A61K31/05 ; A61K9/08 ; A61K47/10 ; A61K47/14 ; A61K47/44 ; A61K9/00 ; A61P25/08
Abstract:
The present invention relates to a cannabinoid containing oral solution. Preferably the oral solution comprises a cannabinoid, a lipid solvent, a sweetener and ethanol, characterised in that the sweetener is an ultrahigh potency sweetener.
Public/Granted literature
- US20190167583A1 ORAL CANNABINOID FORMULATIONS Public/Granted day:2019-06-06
Information query
